GeneFerm Biotechnology Co Ltd Free Cash Flow Generation Index
GeneFerm Biotechnology Co Ltd free cash flow generation index. GeneFerm Biotechnology Co Ltd (1796) has a Free Cash Flow Generation Index of -3.13x as of June 2025. Free cash flow of NT$-4.53 Million represents -3% of operating cash flow (NT$1.45 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of GeneFerm Biotechnology Co Ltd (2017–2024)
Free cash flow generation index of GeneFerm Biotechnology Co Ltd from 2017 to 2024. Historical FCF Generation Index trend for GeneFerm Biotechnology Co Ltd across 8 annual periods. See how financially flexible is GeneFerm Biotechnology Co Ltd to measure the company's free cash flow as a share of total liabilities.
GeneFerm Biotechnology Co Ltd Free Cash Flow Generation Index by Year (2017–2024)
GeneFerm Biotechnology Co Ltd free cash flow generation index by year from 2017 to 2024. Year-by-year Free Cash Flow Generation Index for GeneFerm Biotechnology Co Ltd. For the full cash flow conversion analysis, see GeneFerm Biotechnology Co Ltd operating cash flow efficiency.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.81x | NT$-14.61 Million | NT$8.09 Million | NT$22.70 Million | ▼ -389.0% |
| 2023 | 0.62x | NT$118.91 Million | NT$190.31 Million | NT$71.40 Million | ▲ +149.0% |
| 2022 | -1.27x | NT$-155.98 Million | NT$122.43 Million | NT$278.42 Million | ▼ -328.4% |
| 2021 | -0.30x | NT$-33.37 Million | NT$112.23 Million | NT$145.61 Million | ▲ +35.2% |
| 2020 | -0.46x | NT$-25.90 Million | NT$56.42 Million | NT$82.32 Million | ▲ +83.1% |
| 2019 | -2.72x | NT$-39.89 Million | NT$14.69 Million | NT$54.57 Million | ▼ -995.1% |
| 2018 | 0.30x | NT$12.78 Million | NT$42.14 Million | NT$28.81 Million | ▲ +269.2% |
| 2017 | 0.08x | NT$5.02 Million | NT$61.08 Million | NT$55.16 Million | — |